Cardiovascular drug use and differences in the incidence of cardiovascular mortality in elderly Serbian men
- 39 Downloads
Objective:To assess whether the difference in risk of cardiovascular mortality between urban and rural areas of Serbia could be explained by differences in the use of cardiovascular medication.
Methods: The Serbian cohorts of the Seven Countries Study, Velika Krsna (VK), Zrenjanin (ZR) and Belgrade (BG), were enrolled in 1962-1964 and were followed up for 25 years. The survivors of these cohorts were re-examined in 1987, 1988 and 1989, respectively. This second examination of elderly men aged 65 to 84 years included a questionnaire about current use of cardiovascular medication, risk factors and diseases and a physical examination. All subjects were followed until death or the predefined censor date (10 years after baseline). The Cox proportional hazards model was used to calculate the risk of cardiovascular mortality in the rural cohorts compared to the urban cohort and to adjust for confounding.
Main outcome measure: Cardiovascular death. Results: A total of 227 men from VK, 184 men from ZR and 287 men from BG were followed for a mean duration of 7.4 years and was complete for all subjects. After exclusion of 13 subjects with missing medication data, the incidences of cardiovascular mortality in VK, ZR, and BG were 60, 74, and 26 per 1000 person-years, respectively. The prevalence of cardiovascular medication use was 38% in VK, 52% in ZR, and 59% in BG. The greatest difference in use of specific medication was observed for betablockers (0% in VK and ZR, 13% in BG). After adjustment for cardiovascular risk factors, diseases and age, the relative risks (RRs) of cardiovascular mortality were 2.12 [95% CI: 1.44–3.12], and 2.27 [95% CI: 1.56–3.30] in VK, and ZR compared to BG. Additional adjustment for the use of cardiovascular medication increased these RRs to 2.40 [95% CI: 1.61–3.60] and 2.55 [95% CI: 1.72–3.78], respectively.
Conclusion:The variation in cardiovascular medication use could not explain the excess risk of mortality in the rural Serbian cohorts compared to urban Belgrade.
KeywordsAntihypertensive drugs Cardiovascular drugs Cardiovascular mortality Cohort study Pharmacoepidemiology Serbia Socio-economic class
Unable to display preview. Download preview PDF.
- 1.WHO MONICA Project1987geographic variation in mortality from cardiovascular diseases – baseline data on selected population characteristics and cardiovascular mortalityWorld Health Stat Q4017184Google Scholar
- 2.Nedeljkovic SI, Ostojic MC, Vukotic MR, Grujic MZ. Recent trends in cardiovascular disease and risk factors: Yugoslavia. In: Toshima H, Koga Y, Blackburn H, Keys A, editors. Lessons for Science from Seven Countries Study. Tokyo: Springer, 1994; 75– 91. ISBN: 3540701400.Google Scholar
- 4.Deedwania, PC. 2000HypercholesterolemiaIs lipid-lowering worthwhile for older patients? Geriatrics55228Google Scholar
- 5.Perenboom, RJ, Lako, CJ, Schouten, EG. 1988Health status and medical consumption of rural and urban elderlyCompr Gerontol2124128Google Scholar
- 6.Keys, A, Aravanis, C, Blackburn, HW, Buchem, FSP, Buzina, R, Djordjevic, BS., et al. 1967Epidemiological studies related to coronary heart disease: characteristics of men aged 59 in seven countries.Acta Med Scand4601392Google Scholar
- 7.Anonymous. MRC. Questionnaire on respiratory symptoms. London: The Council, 1986.Google Scholar
- 8.Anonymous. MRC. Questionnaire on respiratory symptoms. Instructions to interviewers. London: The Council, 1986.Google Scholar
- 9.Rose, GA. 1962The diagnosis of ischaemic heart pain and intermittent claudication in field surveysBill WHO2764558Google Scholar
- 10.WHO MONICA Project. Manual of operations – standardization of lipid measurements. WHO/MNC/82. 2; May 1983.Google Scholar
- 11.Anonymous. Anatomical Therapeutical Chemical (ATC) classification index. Oslo: WHO Collaboration Centre for Drugs Statistics Methodology, 2000.Google Scholar
- 12.Cox, DR. 1972Regression models and lifetablesJ R Stat Soc2187220Google Scholar